198 related articles for article (PubMed ID: 23848392)
1. Mean corpuscular volume is associated with endothelial dysfunction and predicts composite cardiovascular events in patients with chronic kidney disease.
Solak Y; Yilmaz MI; Saglam M; Demirbas S; Verim S; Unal HU; Gaipov A; Oguz Y; Kayrak M; Caglar K; Vural A; Turk S; Covic A; Kanbay M
Nephrology (Carlton); 2013 Nov; 18(11):728-35. PubMed ID: 23848392
[TBL] [Abstract][Full Text] [Related]
2. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients.
Kanbay M; Yilmaz MI; Apetrii M; Saglam M; Yaman H; Unal HU; Gok M; Caglar K; Oguz Y; Yenicesu M; Cetinkaya H; Eyileten T; Acikel C; Vural A; Covic A
Am J Nephrol; 2012; 36(3):228-37. PubMed ID: 22948239
[TBL] [Abstract][Full Text] [Related]
3. The relationship between IL-10 levels and cardiovascular events in patients with CKD.
Yilmaz MI; Solak Y; Saglam M; Cayci T; Acikel C; Unal HU; Eyileten T; Oguz Y; Sari S; Carrero JJ; Stenvinkel P; Covic A; Kanbay M
Clin J Am Soc Nephrol; 2014 Jul; 9(7):1207-16. PubMed ID: 24789549
[TBL] [Abstract][Full Text] [Related]
4. Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes.
Yilmaz MI; Stenvinkel P; Sonmez A; Saglam M; Yaman H; Kilic S; Eyileten T; Caglar K; Oguz Y; Vural A; Çakar M; Altun B; Yenicesu M; Carrero JJ
Nephrol Dial Transplant; 2011 Nov; 26(11):3537-43. PubMed ID: 21378154
[TBL] [Abstract][Full Text] [Related]
5. Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients.
Kanbay M; Siriopol D; Saglam M; Kurt YG; Gok M; Cetinkaya H; Karaman M; Unal HU; Oguz Y; Sari S; Eyileten T; Goldsmith D; Vural A; Veisa G; Covic A; Yilmaz MI
J Clin Endocrinol Metab; 2014 Oct; 99(10):E1854-61. PubMed ID: 25057883
[TBL] [Abstract][Full Text] [Related]
6. Red cell distribution width is independently related to endothelial dysfunction in patients with chronic kidney disease.
Solak Y; Yilmaz MI; Saglam M; Caglar K; Verim S; Unal HU; Gok M; Demirkaya E; Gaipov A; Kayrak M; Cetinkaya H; Eyileten T; Turk S; Vural A
Am J Med Sci; 2014 Feb; 347(2):118-24. PubMed ID: 23928544
[TBL] [Abstract][Full Text] [Related]
7. Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients.
Tabata N; Hokimoto S; Akasaka T; Arima Y; Sakamoto K; Yamamoto E; Tsujita K; Izumiya Y; Yamamuro M; Kojima S; Kaikita K; Ogawa H
Heart Vessels; 2016 Jul; 31(7):1038-44. PubMed ID: 26164597
[TBL] [Abstract][Full Text] [Related]
8. Serum uric acid independently predicts cardiovascular events in advanced nephropathy.
Kanbay M; Yilmaz MI; Sonmez A; Solak Y; Saglam M; Cakir E; Unal HU; Arslan E; Verim S; Madero M; Caglar K; Oguz Y; McFann K; Johnson RJ
Am J Nephrol; 2012; 36(4):324-31. PubMed ID: 23007099
[TBL] [Abstract][Full Text] [Related]
9. IL-33 and ST2 levels in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events, and survival.
Gungor O; Unal HU; Guclu A; Gezer M; Eyileten T; Guzel FB; Altunoren O; Erken E; Oguz Y; Kocyigit I; Yilmaz MI
PLoS One; 2017; 12(6):e0178939. PubMed ID: 28614418
[TBL] [Abstract][Full Text] [Related]
10. Associations among chronic kidney disease, high total p-cresylsulfate and major adverse cardiac events.
Wang CP; Lu LF; Yu TH; Hung WC; Chiu CA; Chung FM; Hsu CC; Lu YC; Lee YJ; Houng JY
J Nephrol; 2013; 26(1):111-8. PubMed ID: 22460182
[TBL] [Abstract][Full Text] [Related]
11. Thyroid function and cardiovascular events in chronic kidney disease patients.
Afsar B; Yilmaz MI; Siriopol D; Unal HU; Saglam M; Karaman M; Gezer M; Sonmez A; Eyileten T; Aydin I; Hamcan S; Oguz Y; Covic A; Kanbay M
J Nephrol; 2017 Apr; 30(2):235-242. PubMed ID: 27039198
[TBL] [Abstract][Full Text] [Related]
12. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
[TBL] [Abstract][Full Text] [Related]
13. Assessment of endothelial dysfunction in Asian Indian patients with chronic kidney disease and changes following renal transplantation.
Sharma J; Kapoor A; Muthu R; Prasad N; Sinha A; Khanna R; Kumar S; Garg N; Tewari S; Sharma RK; Goel P
Clin Transplant; 2014 Aug; 28(8):889-96. PubMed ID: 24930933
[TBL] [Abstract][Full Text] [Related]
14. The significance of micro- and macrovascular biomarkers on cardiovascular outcome in chronic kidney disease: a prospective cohort study.
Cseprekál O; Egresits J; Tabák Á; Nemcsik J; Járai Z; Babos L; Fodor E; Farkas K; Godina G; Kárpáthi KI; Kerkovits L; Marton A; Nemcsik-Bencze Z; Németh Z; Sallai L; Kiss I; Tislér A
J Hum Hypertens; 2016 Jul; 30(7):449-55. PubMed ID: 26424101
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of home blood pressure control on renal and cardiovascular outcomes in elderly patients with chronic kidney disease.
Okada T; Nakao T; Matsumoto H; Nagaoka Y; Tomaru R; Iwasawa H; Wada T
Hypertens Res; 2009 Dec; 32(12):1123-9. PubMed ID: 19816503
[TBL] [Abstract][Full Text] [Related]
16. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index.
Brevetti G; Silvestro A; Schiano V; Chiariello M
Circulation; 2003 Oct; 108(17):2093-8. PubMed ID: 14530195
[TBL] [Abstract][Full Text] [Related]
17. Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality.
Tsagalis G; Akrivos T; Alevizaki M; Manios E; Stamatellopoulos K; Laggouranis A; Vemmos KN
Nephrol Dial Transplant; 2009 Jan; 24(1):194-200. PubMed ID: 18728156
[TBL] [Abstract][Full Text] [Related]
18. Aortic pulse wave velocity predicts mortality in chronic kidney disease stages 2-4.
Baumann M; Wassertheurer S; Suttmann Y; Burkhardt K; Heemann U
J Hypertens; 2014 Apr; 32(4):899-903. PubMed ID: 24609217
[TBL] [Abstract][Full Text] [Related]
19. Visceral obesity assessed by computed tomography predicts cardiovascular events in chronic kidney disease patients.
Kamimura MA; Carrero JJ; Canziani ME; Watanabe R; Lemos MM; Cuppari L
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):891-7. PubMed ID: 22841184
[TBL] [Abstract][Full Text] [Related]
20. Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients.
Liabeuf S; Lenglet A; Desjardins L; Neirynck N; Glorieux G; Lemke HD; Vanholder R; Diouf M; Choukroun G; Massy ZA;
Kidney Int; 2012 Dec; 82(12):1297-303. PubMed ID: 22895515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]